# mana.bio: Research, San Francisco, United States

> mana.bio: Mana.bio is an AI-based biotechnology startup founded in 2021, focused on enhancing targeted gene therapy delivery.

Source: https://millionrounds.com/startup/mana-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# mana.bio

Mana.bio is an AI-based biotechnology startup founded in 2021, focused on enhancing targeted gene therapy delivery.

Funding reported Last round: Seed

Research San Francisco, United States

Company summary

- **Founded:** 2021 5 years old
- **Team:** 21 11 to 50 people
- **Funding reported:** $30M in dollars
- **Last round:** Seed Oct 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for mana.bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About mana.bio

Mana.bio is an AI-based biotechnology startup founded in 2021, focused on enhancing targeted gene therapy delivery.

The company combines machine learning with lipid nanoparticle (LNP) engineering to create solutions for drug delivery beyond the liver. Its proprietary platform is designed for programmable LNPs that support various oligonucleotide therapies, including RNA and DNA-based therapeutics, vaccines, and CRISPR gene editing tools. The core service of Mana.bio is its AI-driven LNP discovery platform, which utilizes a high-throughput Design-Build-Test-Learn cycle to identify optimal LNP formulations for specific payloads. The company also launched MinaTM, a large language model specifically for lipid nanoparticles, aimed at accelerating scientific discovery. Mana.bio collaborates with biotechnology and pharmaceutical companies to optimize formulations for cell-specific delivery, addressing significant challenges in gene therapy. Headquartered in Tel Aviv, Israel, the company has raised $19.5 million in funding and employs a team of experts in drug delivery, machine learning, and software development.

## What company datasets say mana.bio raised

Funding, as reported

Reported in all **$30M** in dollars

Rounds **3**

Last round **Seed**

Last round size **$15M**

Last round date **Oct 2023**

Investors listed **5**

## Founders and team

From mana.bio's own website: 4 founders.

**Yogev Debbi** Co-Founder & CEO

**Roy Nevo** Co-Founder & CTO

**Dr. Kira Radinsky** Scientific co-founder

**Prof. Avi Schroeder** Scientific co-founder

## On 3 portfolio pages

Investors who name them

- [Bluezone Capital](https://millionrounds.com/fund/bluezone-capital)
- [Shane Neman](https://millionrounds.com/fund/shane-neman)
- [LionBird](https://millionrounds.com/fund/lionbird)

Each firm lists mana.bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

gene therapy delivery health care biotechnology research manufacturing lipid nanoparticle design biotech seed stage lnp formulation medical research tissue-specific delivery information technology & services rna vaccines formulation optimization biotech research biotech collaborations nanoparticle synthesis ai platform

Built with from their website

Google Tag Manager Gunicorn Google Cloud Google Workspace Viewport Meta Varnish webpack Google Cloud Hosting AI Google Meet

+8 more

Priority Hints React Google Font API Sirvoy Wix eCommerce WebsiteBuilder Mobile Friendly Lodash

- **Sector:** Research
- **Industry code:** NAICS 541714, 541713, SIC 8731
- **Region:** California
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/mana-bio)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put mana.bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)